Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma

Por Creach, Kimberly M., Siegel, Barry A., Nussenbaum, Brian, Grigsby, Perry W.
Publicado em 2012

Survival of Patients Evaluated by FDG-PET Before Hepatic Resection for Metastatic Colorectal Carcinoma: A Prospective Database Study

Por Strasberg, Steven M., Dehdashti, Farrokh, Siegel, Barry A., Drebin, Jeffrey A., Linehan, David
Publicado em 2001

Qualification of PET Scanners for Use in Multicenter Cancer Clinical Trials: The American College of Radiology Imaging Network Experience

Por Scheuermann, Joshua S., Saffer, Janet R., Karp, Joel S., Levering, Anthony M., Siegel, Barry A.
Publicado em 2009

Changes in Cervical Cancer FDG Uptake During Chemoradiation and Association with Response

Por Kidd, Elizabeth A., Thomas, Maria, Siegel, Barry A., Dehdashti, Farrokh, Grigsby, Perry W.
Publicado em 2012

Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Resu...

Por Markovina, Stephanie, Duan, Fenghai, Snyder, Bradley S., Siegel, Barry A., Machtay, Mitchell, Bradley, Jeffrey
Publicado no Int J Radiat Oncol Biol Phys (2015)

FDG-PET-based prognostic nomograms for locally advanced cervical cancer

Por Kidd, Elizabeth A., El Naqa, Issam, Siegel, Barry A., Dehdashti, Farrokh, Grigsby, Perry W.
Publicado em 2012

The Lack of Evidence for PET or PET-CT Surveillance of Patients with Treated Lymphoma, Colorectal Cancer, and Head and Neck Cancer: A Systematic Review

Por Patel, Kamal, Hadar, Nira, Lee, Jounghee, Siegel, Barry A., Hillner, Bruce E., Lau, Joseph
Publicado em 2013

Positron Emission Tomography with [(18)F]-3′-deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: A Pilot Study

Por Dehdashti, Farrokh, Grigsby, Perry W., Myerson, Robert J., Nalbantoglu, ILKe, Ma, Changqing, Siegel, Barry A.
Publicado em 2013

(18)F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation

Por Cashen, Amanda F., Dehdashti, Farrokh, Luo, Jingqin, Homb, Andrew, Siegel, Barry A., Bartlett, Nancy L.
Publicado em 2011

An Imaging Comparison of (64)Cu-ATSM and (60)Cu-ATSM in Cancer of the Uterine Cervix

Por Lewis, Jason S., Laforest, Richard, Dehdashti, Farrokh, Grigsby, Perry W., Welch, Michael J., Siegel, Barry A.
Publicado no J Nucl Med (2008)

PET/CT is a cost-effective tool against cancer: synergy supersedes singularity

Por Fischer, Barbara Malene, Siegel, Barry A., Weber, Wolfgang A., von Bremen, Konrade, Beyer, Thomas, Kalemis, Antonis
Publicado no Eur J Nucl Med Mol Imaging (2016)

Five-Year Survival After Resection of Hepatic Metastases From Colorectal Cancer in Patients Screened by Positron Emission Tomography With F-18 Fluorodeoxyglucose (FDG-PET)

Por Fernandez, Felix G., Drebin, Jeffrey A., Linehan, David C., Dehdashti, Farrokh, Siegel, Barry A., Strasberg, Steven M.
Publicado em 2004

Impact on Patient Management of [(18)F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry

Por Subramaniam, Rathan M., Shields, Anthony F., Sachedina, Archana, Hanna, Lucy, Duan, Fenghai, Siegel, Barry A., Hillner, Bruce E.
Publicado no Oncologist (2016)

Impact of Dedicated Brain PET on Intended Patient Management in Participants of the National Oncologic PET Registry

Por Hillner, Bruce E., Siegel, Barry A., Shields, Anthony F., Duan, Fenghai, Gareen, Ilana F., Hanna, Lucy, Coleman, R. Edward
Publicado em 2010

Growth in Use of Positron Emission Tomography for Six Cancer Types after Coverage by Medicare: Additive or Replacement?

Por Hillner, Bruce E., Tosteson, Anna N., Song, Yunjie, Tosteson, Tor D., Onega, Tracy, Goodman, David C., Siegel, Barry A.
Publicado em 2012

Geographic and Sociodemographic Disparities in PET Use by Medicare Beneficiaries With Cancer

Por Onega, Tracy, Tosteson, Tor D., Wang, Qianfei, Hillner, Bruce E., Song, Yunjie, Siegel, Barry A., Tosteson, Anna N. A.
Publicado em 2012

A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck

Por Adkins, Douglas, Ley, Jessica, Dehdashti, Farrokh, Siegel, Marilyn J, Wildes, Tanya M, Michel, Loren, Trinkaus, Kathryn, Siegel, Barry A
Publicado no Cancer Med (2014)

Reliability of PET/CT Shape and Heterogeneity Features in Functional and Morphologic Components of Non–Small Cell Lung Cancer Tumors: A Repeatability Analysis in a Prospective Mult...

Por Desseroit, Marie-Charlotte, Tixier, Florent, Weber, Wolfgang A., Siegel, Barry A., Cheze Le Rest, Catherine, Visvikis, Dimitris, Hatt, Mathieu
Publicado no J Nucl Med (2017)

Intended Versus Inferred Care After PET Performed for Initial Staging in the National Oncologic PET Registry

Por Hillner, Bruce E., Tosteson, Anna N.A., Tosteson, Tor D., Wang, Qianfei, Song, Yunjie, Hanna, Lucy G., Siegel, Barry A.
Publicado em 2013

Metabolic Tumor Volume Predicts Overall Survival and Local Control in Patients with Stage III Non-Small Cell Lung Cancer Treated on ACRIN 6668/RTOG 0235

Por Bazan, Jose G., Duan, Fenghai, Snyder, Bradley S., Horng, Dunstan, Graves, Edward E., Siegel, Barry A., Machtay, Mitchell, Loo, Billy W.
Publicado no Eur J Nucl Med Mol Imaging (2016)